Applications of novel monoclonal antibodies specific for synuclein-gamma in evaluating its levels in sera and cancer tissues from colorectal cancer patients.
about
Unconventional secretion of synuclein-γ promotes tumor cell invasionSynuclein gamma predicts poor clinical outcome in colon cancer with normal levels of carcinoembryonic antigensiRNA-Mediated Suppression of Synuclein γ Inhibits MDA-MB-231 Cell Migration and Proliferation by Downregulating the Phosphorylation of AKT and ERKIdentification of γ-synuclein as a stage-specific marker in bladder cancer by immunohistochemistry.Expression of ERα, its ERαΔ3 Splice Variant and γ-SYNUCLEIN in Ovarian Cancer: A Pilot Study.Synuclein-γ (SNCG) expression in ovarian cancer is associated with high-risk clinicopathologic disease.Urine gamma-synuclein as a biomarker for the diagnosis of bladder cancer.Long non-coding RNA AK058003, as a precursor of miR-15a, interacts with HuR to inhibit the expression of γ-synuclein in hepatocellular carcinoma cells.Synuclein gamma protects HER2 and renders resistance to Hsp90 disruption.Synuclein γ protects Akt and mTOR and renders tumor resistance to Hsp90 disruption.Synuclein-γ in uterine serous carcinoma impacts survival: An NRG Oncology/Gynecologic Oncology Group study.Clinical study of the relationship between γ-synuclein and the response of neoadjuvant chemotherapy in breast cancer.Role and Characterization of Synuclein-γ Unconventional Protein Secretion in Cancer Cells.Extracellular gamma-synuclein promotes tumor cell motility by activating β1 integrin-focal adhesion kinase signaling pathway and increasing matrix metalloproteinase-24, -2 protein secretion.
P2860
Q24304136-D1E55B15-ADCC-4E90-8512-0A3490F743C6Q33626102-DE82826C-F48A-4D11-AAAF-6DEB18B93270Q34340575-04A8F648-DE60-43A7-8E40-01B771B422BDQ34700572-7B6469FE-156E-4370-BF40-565F590EA2A7Q35534334-62F07802-3224-4080-8573-AA2B8F7983B3Q37391092-B7CC63CB-CDC7-443D-A578-DD4755B30EDBQ37536597-86C06BB9-3755-4D9C-90A2-39D7ABCC84B0Q37705985-FD94ADCE-B808-4A08-BDE7-4F00A4657DA9Q38977711-809E9D4F-5665-40C5-A5C7-9283C4F40BA1Q38982175-39277F91-4F81-46E5-AF73-7D01E3846C8BQ39123683-906BD4D0-62AB-40F8-93AA-B7DC6507F11DQ44700598-6E8602CD-A943-431B-8EB8-3487CF53ED20Q51465451-1C49A567-4F6D-40D9-B934-06AA62E0BDC6Q55332346-3B885A60-9D83-49CF-98D8-193BB486CFB5
P2860
Applications of novel monoclonal antibodies specific for synuclein-gamma in evaluating its levels in sera and cancer tissues from colorectal cancer patients.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Applications of novel monoclon ...... om colorectal cancer patients.
@en
Applications of novel monoclon ...... om colorectal cancer patients.
@nl
type
label
Applications of novel monoclon ...... om colorectal cancer patients.
@en
Applications of novel monoclon ...... om colorectal cancer patients.
@nl
prefLabel
Applications of novel monoclon ...... om colorectal cancer patients.
@en
Applications of novel monoclon ...... om colorectal cancer patients.
@nl
P2093
P921
P1433
P1476
Applications of novel monoclon ...... om colorectal cancer patients.
@en
P2093
Caiyun Liu
Chengchao Shou
Jianping Guo
P304
P356
10.1016/J.CANLET.2008.04.037
P407
P577
2008-06-30T00:00:00Z